We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current JSPR market cap is 369.37M. The company's latest EPS is USD -4.2794 and P/E is -5.73.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -12.71M | -13.75M | -13.95M | -17.83M | -19.36M |
Net Income | -11.86M | -13.21M | -14.26M | -16.08M | -17.54M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -136k | -935k | -36.83M | -51.2M | -68.86M |
Net Income | 2k | -591k | -30.64M | -37.69M | -64.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 59.11M | 48.36M | 138.76M | 124.17M | 110.41M |
Total Liabilities | 11.55M | 12.37M | 13.56M | 13.97M | 16.27M |
Total Equity | 47.57M | 35.99M | 125.2M | 110.21M | 94.13M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 101.69M | 101.26M | 93.65M | 48.36M | 94.89M |
Total Liabilities | 3.61M | 3.77M | 24.14M | 12.37M | 16.45M |
Total Equity | 5M | 5M | 69.52M | 35.99M | 78.44M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -33.21M | -45.86M | -10.34M | -23.61M | -35.59M |
Investing | -494k | -576k | -26k | -37k | -37k |
Financing | 27k | 55k | 101.51M | 101.21M | 101.24M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -367k | -641k | -33.68M | -45.86M | -52.07M |
Investing | -100M | 198k | -2.43M | -576k | -267k |
Financing | 101.58M | N/A | 100.97M | 55k | 100.97M |
Market Cap | 369.37M |
Price to Earnings Ratio | -5.73 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4.25 |
Price to Book Ratio | 4.71 |
Dividend Yield | - |
Shares Outstanding | 15.06M |
Average Volume (1 week) | 63.62k |
Average Volume (1 Month) | 69.49k |
52 Week Change | 94.60% |
52 Week High | 31.01 |
52 Week Low | 4.00 |
Spread (Intraday) | 2.57 (9.82%) |
Company Name | Jasper Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.jaspertherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions